Wuxi Biologics Cayman Inc.Wuxi Biologics Cayman Inc.Wuxi Biologics Cayman Inc.

Wuxi Biologics Cayman Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪9.15 B‬USD
0.09USD
‪480.97 M‬USD
‪2.41 B‬USD
‪3.55 B‬
Beta (1Y)
1.74
Employees (FY)
‪12.74 K‬
Change (1Y)
+367 +2.97%
Revenue / Employee (1Y)
‪189.16 K‬USD
Net income / Employee (1Y)
‪37.75 K‬USD

About WUXI BIOLOGICS (CAYMAN) INC


CEO
Zhi Sheng Chen
Headquarters
Wuxi
Founded
2014
FIGI
BBG00HW3DBW6
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of WXIBF is 2.25 USD — it has decreased by −10.00% in the past 24 hours. Watch Wuxi Biologics Cayman Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Wuxi Biologics Cayman Inc. stocks are traded under the ticker WXIBF.
WXIBF stock has fallen by −9.27% compared to the previous week, the month change is a −9.27% fall, over the last year Wuxi Biologics Cayman Inc. has showed a −65.38% decrease.
We've gathered analysts' opinions on Wuxi Biologics Cayman Inc. future price: according to them, WXIBF price has a max estimate of 4.47 USD and a min estimate of 1.27 USD. Watch WXIBF chart and read a more detailed Wuxi Biologics Cayman Inc. stock forecast: see what analysts think of Wuxi Biologics Cayman Inc. and suggest that you do with its stocks.
WXIBF reached its all-time high on Nov 16, 2020 with the price of 34.25 USD, and its all-time low was 1.30 USD and was reached on Aug 22, 2024. View more price dynamics on WXIBF chart.
See other stocks reaching their highest and lowest prices.
WXIBF stock is 11.11% volatile and has beta coefficient of 1.74. Track Wuxi Biologics Cayman Inc. stock price on the chart and check out the list of the most volatile stocks — is Wuxi Biologics Cayman Inc. there?
Today Wuxi Biologics Cayman Inc. has the market capitalization of ‪9.15 B‬, it has decreased by −0.63% over the last week.
Yes, you can track Wuxi Biologics Cayman Inc. financials in yearly and quarterly reports right on TradingView.
Wuxi Biologics Cayman Inc. is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
WXIBF earnings for the last half-year are 0.05 USD per share, whereas the estimation was 0.06 USD, resulting in a −14.63% surprise. The estimated earnings for the next half-year are 0.06 USD per share. See more details about Wuxi Biologics Cayman Inc. earnings.
Wuxi Biologics Cayman Inc. revenue for the last half-year amounts to ‪1.18 B‬ USD, despite the estimated figure of ‪1.15 B‬ USD. In the next half-year revenue is expected to reach ‪1.34 B‬ USD.
WXIBF net income for the last half-year is ‪207.98 M‬ USD, while the previous report showed ‪156.72 M‬ USD of net income which accounts for 32.71% change. Track more Wuxi Biologics Cayman Inc. financial stats to get the full picture.
No, WXIBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has ‪12.74 K‬ employees. See our rating of the largest employees — is Wuxi Biologics Cayman Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Wuxi Biologics Cayman Inc. EBITDA is ‪685.90 M‬ USD, and current EBITDA margin is 31.22%. See more stats in Wuxi Biologics Cayman Inc. financial statements.
Like other stocks, WXIBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Wuxi Biologics Cayman Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Wuxi Biologics Cayman Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Wuxi Biologics Cayman Inc. stock shows the sell signal. See more of Wuxi Biologics Cayman Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.